Recent News

• 03.03.2025 - Ashland increases prices for 1-4 Butanediol intermediates and solvents product range globally
• 02.14.2025 - Ashland Launches Gafchromic™ In-Vivo Dosimetry System
• 02.04.2025 - Ashland announces compliance of viatelTM lactide/glycolide polymers versus upcoming LG polymer USP-NF monographs.
• 01.29.2025 - 1st Quarter 2025 Earnings Call
• 01.28.2025 - Ashland reports financial results for first quarter fiscal 2025¹, reiterates outlook for full-year fiscal 2025
• 01.28.2025 - Ashland reports financial results for first quarter fiscal 2025¹, reiterates outlook for full-year fiscal 2025

Recent Filings

• 02.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.31.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 01.29.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 01.28.2025 - EX-99.1 EX-99.1
• 01.28.2025 - 8-K Current report
• 01.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.23.2025 - 4 Statement of changes in beneficial ownership of securities